Gemple Biotechnology

Gemple Biotechnology, officially Shanghai Gemple Biotech, is a China-based life science company focused on genetic and rare diseases. The company combines newborn and carrier screening, molecular diagnostic testing, clinical laboratory services, and translational research tools into an end-to-end offering from screening and diagnosis through disease modeling and early therapeutic exploration. Its technology base includes high-throughput sequencing, chromosome microarray and related genomics workflows, CRISPR/Cas9 gene editing, and induced pluripotent stem cell platforms. Gemple also operates rare-disease-focused iPSC resources and provides research services such as cell line generation, gene editing, and directed differentiation. Commercial activity appears centered on diagnostics, IVD products, and translational research services rather than a traditional clinical-stage drug pipeline.